Sökning: onr:"swepub:oai:DiVA.org:oru-105864" >
Treatment of Gestat...
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
-
- Simmons, David (författare)
- Western Sydney University, Campbelltown, NSW, Australia
-
- Immanuel, Jincy (författare)
- Western Sydney University, Campbelltown, NSW, Australia
-
- Hague, William M. (författare)
- Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
-
visa fler...
-
- Teede, Helena (författare)
- Monash University, Melbourne, Australia
-
- Nolan, Christopher J. (författare)
- Canberra Hospital, Canberra, ACT, Australia; Australian National University, Canberra, ACT, Australia
-
- Peek, Michael J. (författare)
- Australian National University, Canberra, ACT, Australia
-
- Flack, Jeff R. (författare)
- Bankstown-Lidcombe Hospital, Australia
-
- McLean, Mark (författare)
- Blacktown Hospital, Sydney, Australia
-
- Wong, Vincent (författare)
- Liverpool Hospital and University of New South Wales, Sydney, Australia
-
- Hibbert, Emily (författare)
- Nepean Clinical School, University of Sydney, Sydney, Australia; Nepean Hospital, Sydney, Australia
-
- Kautzky-Willer, Alexandra (författare)
- Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
-
- Harreiter, Jürgen (författare)
- Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
-
- Backman, Helena, 1965- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Obstetrics and Gynecology
-
- Gianatti, Emily (författare)
- Department of Endocrinology, Fiona Stanley Hospital, Murdoch, WA, Australia
-
- Sweeting, Arianne (författare)
- Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia
-
- Mohan, Viswanathan (författare)
- Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, India
-
- Enticott, Joanne (författare)
- Canberra Hospital, Australia; Australian National University, Australia
-
- Cheung, N. Wah (författare)
- Westmead Hospital, Sydney, Austrlia
-
TOBOGM Research Group, - (bidragsgivare)
-
visa färre...
-
(creator_code:org_t)
- Massachusetts Medical Society, 2023
- 2023
- Engelska.
-
Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 388:23, s. 2132-2144
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Whether treatment of gestational diabetes before 20 weeks' gestation improves maternal and infant health is unclear.METHODS: We randomly assigned, in a 1:1 ratio, women between 4 weeks' and 19 weeks 6 days' gestation who had a risk factor for hyperglycemia and a diagnosis of gestational diabetes (World Health Organization 2013 criteria) to receive immediate treatment for gestational diabetes or deferred or no treatment, depending on the results of a repeat oral glucose-tolerance test [OGTT] at 24 to 28 weeks' gestation (control). The trial included three primary outcomes: a composite of adverse neonatal outcomes (birth at <37 weeks' gestation, birth trauma, birth weight of ≥4500 g, respiratory distress, phototherapy, stillbirth or neonatal death, or shoulder dystocia), pregnancy-related hypertension (preeclampsia, eclampsia, or gestational hypertension), and neonatal lean body mass.RESULTS: A total of 802 women underwent randomization; 406 were assigned to the immediate-treatment group and 396 to the control group; follow-up data were available for 793 women (98.9%). An initial OGTT was performed at a mean (±SD) gestation of 15.6±2.5 weeks. An adverse neonatal outcome event occurred in 94 of 378 women (24.9%) in the immediate-treatment group and in 113 of 370 women (30.5%) in the control group (adjusted risk difference, -5.6 percentage points; 95% confidence interval [CI], -10.1 to -1.2). Pregnancy-related hypertension occurred in 40 of 378 women (10.6%) in the immediate-treatment group and in 37 of 372 women (9.9%) in the control group (adjusted risk difference, 0.7 percentage points; 95% CI, -1.6 to 2.9). The mean neonatal lean body mass was 2.86 g in the immediate-treatment group and 2.91 g in the control group (adjusted mean difference, -0.04 g; 95% CI, -0.09 to 0.02). No between-group differences were observed with respect to serious adverse events associated with screening and treatment.CONCLUSIONS: Immediate treatment of gestational diabetes before 20 weeks' gestation led to a modestly lower incidence of a composite of adverse neonatal outcomes than no immediate treatment; no material differences were observed for pregnancy-related hypertension or neonatal lean body mass. (Funded by the National Health and Medical Research Council and others; TOBOGM Australian New Zealand Clinical Trials Registry number, ACTRN12616000924459.).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Simmons, David
-
Immanuel, Jincy
-
Hague, William M ...
-
Teede, Helena
-
Nolan, Christoph ...
-
Peek, Michael J.
-
visa fler...
-
Flack, Jeff R.
-
McLean, Mark
-
Wong, Vincent
-
Hibbert, Emily
-
Kautzky-Willer, ...
-
Harreiter, Jürge ...
-
Backman, Helena, ...
-
Gianatti, Emily
-
Sweeting, Ariann ...
-
Mohan, Viswanath ...
-
Enticott, Joanne
-
Cheung, N. Wah
-
TOBOGM Research ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
New England Jour ...
- Av lärosätet
-
Örebro universitet